Under its PCT WO 02/074337 (patent already granted in Europe EP1368060, Mexico MXPA03008364
and Australia AU2002/247977) Bio3 Research has conducted, in collaboration with
Veterinary Faculty of Milano University, preliminary pharmacological studies in
animals by utilizing HMGB1 in Cartilage Repair with encouraging results.
Bio3 News...
Bio3 Research has recently been granted from USPTO the
US
patent # 10/471,641 which claims the use of HMGB1 inhibitors and antagonists for
the treatment of Cardiovascular Disorders…
